We are live on ! Find out more
PM

Parametrica Management Portfolio holdings

AUM $88M
1-Year Est. Return 48.84%
This Fund
S&P 500
This Quarter Est. Return
+28.81%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$55.4M
AUM Growth
+$6.65M
Cap. Flow
-$139K
Cap. Flow %
-0.25%
Top 10 Hldgs %
76.73%
Holding
54
New
8
Increased
11
Reduced
5
Closed
28

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$3.86M
2
BEKE icon
KE Holdings
BEKE
+$3.77M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.15M
4
MSFT icon
Microsoft
MSFT
+$2.75M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.36M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$3.82M
2
JD icon
JD.com
JD
+$3.46M
3
BABA icon
Alibaba
BABA
+$3.27M
4
WOLF icon
Wolfspeed
WOLF
+$2.31M
5
IBB icon
iShares Biotechnology ETF
IBB
+$1.93M

Sector Composition

Rank Sector Weight
1 Communication Services 34.96%
2 Technology 28.81%
3 Healthcare 20.59%
4 Consumer Discretionary 8.71%
5 Real Estate 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDAK
26
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$11K 0.02%
65,098
– –
AAPL icon
27
Apple
AAPL
$4.97T
– –
-6,998
Closed -$909K
ASML icon
28
ASML
ASML
$596B
– –
-1,020
Closed -$557K
BABA icon
29
Alibaba
BABA
$276B
– –
-37,100
Closed -$3.27M
BALL icon
30
Ball Corp
BALL
$17.5B
– –
-4,808
Closed -$246K
BB icon
31
BlackBerry
BB
$4.58B
– –
-13,180
Closed -$42.9K
BILI icon
32
Bilibili
BILI
$7.75B
– –
-36,900
Closed -$874K
CLOV icon
33
Clover Health Investments
CLOV
$2.23B
– –
-36,627
Closed -$34K
DAL icon
34
Delta Air Lines
DAL
$56.7B
– –
-19,768
Closed -$650K
DE icon
35
Deere & Co
DE
$165B
– –
-528
Closed -$226K
IBB icon
36
iShares Biotechnology ETF
IBB
$9.45B
– –
-14,700
Closed -$1.93M
JD icon
37
JD.com
JD
$43.5B
– –
-61,600
Closed -$3.46M
LAZR
38
DELISTED
Luminar Technologies
LAZR
– –
-902
Closed -$66.8K
LUV icon
39
Southwest Airlines
LUV
$21.7B
– –
-34,103
Closed -$1.15M
NXST icon
40
Nexstar Media Group
NXST
$6.01B
– –
-3,144
Closed -$550K
PFE icon
41
Pfizer
PFE
$143B
– –
-74,599
Closed -$3.82M
PTON icon
42
Peloton Interactive
PTON
$2.85B
– –
-12,003
Closed -$95.4K
SIRI icon
43
SiriusXM
SIRI
$11B
– –
-2,165
Closed -$126K
FIRY
44
Firy Inc
FIRY
$154M
– –
-1,089
Closed -$11K
SYF icon
45
Synchrony
SYF
$24.4B
– –
-6,476
Closed -$213K
TAL icon
46
TAL Education Group
TAL
$6.04B
– –
-36,832
Closed -$260K
TTE icon
47
TotalEnergies
TTE
$193B
– –
-3,720
Closed -$231K
WOLF icon
48
Wolfspeed
WOLF
$1.04B
– –
-33,421
Closed -$2.31M
XLI icon
49
State Street Industrial Select Sector SPDR ETF
XLI
$32.2B
– –
-10,400
Closed -$1.02M
SGI
50
Somnigroup International
SGI
$14.4B
– –
-27,068
Closed -$929K
1
2
3

Similar funds

BCP
Balance Capital Partners New York $87.9M AUM
PBCM
Point Break Capital Management Miami, Florida $88M AUM
CVM
Civilization Ventures Management Belvedere Tiburon, California $87.9M AUM
XXIP
Xiamen Xinweidachuang Investment Partnership Xiamen, China $87.8M AUM 29.25% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
RFL
RD Finance Ltd Limassol, Cyprus $88.1M AUM 11.44% 1-Year Est. Return
IAP
Indie Asset Partners Carmel, Indiana $87.8M AUM 27.76% 1-Year Est. Return
MPEM
Marathon Partners Equity Management New York $88.3M AUM 20.65% 1-Year Est. Return

Parametrica Management's Q1 2023 Portfolio in Review

As of Q1 2023, Parametrica Management held 54 positions worth $55.4M, up 14% from $48.8M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Parametrica Management's Q1 2023 filing shows 8 new, 11 increased, 5 reduced and 28 closed positions. Its largest new stake was KE Holdings: 203,892 shares worth $3.84M. The largest sale was Pfizer, an estimated $3.82M.

By sector, the portfolio is most concentrated in Communication Services at 35% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Parametrica Management's largest Q1 2023 buy was KE Holdings: 203,892 shares worth $3.84M.
  • Parametrica Management added most to Meta Platforms (Facebook) in Q1 2023, an estimated $3.86M increase.
  • Parametrica Management's biggest Q1 2023 reduction was Alnylam Pharmaceuticals, cutting an estimated $746K.
  • Parametrica Management fully exited Pfizer in Q1 2023, selling an estimated $3.82M.
  • Parametrica Management's ten largest holdings make up 77% of its $55.4M portfolio in Q1 2023.
  • Parametrica Management opened 8 new positions and closed 28 in Q1 2023.
  • Parametrica Management's portfolio value rose 14% quarter-over-quarter to $55.4M.

Based on Parametrica Management's 13F filing for Q1 2023, filed 9 May 2023.